Synthesis and Computational Insights of p-Benzoyl-Phenylalanine as Potential Estrogen Receptor Inhibitor

This is the authors' abstract. We don't add key points for this paper.

Radiolabelled amino acids have been gaining great interest in medical field both as diagnostic and therapeutic agents. New pharmaceutical compound, p-benzoyl-phenylalanine (4-BP), was synthesised and investigated for its potential as estrogen receptor inhibitor for breast cancer and characterised using FT-IR, 1H and 13C-NMR spectroscopic techniques. The molecular docking study were carried out to explore the molecular interactions between 4-BP and human estrogen receptor (hERα). Docking results revealed 4-BP has high binding affinity via hydrophobic and polar-polar contacts towards hERα. Analysis of 30 ns molecular dynamics simulations results of the best docked 4-OHT and 4-BP with hERα receptor demonstrate stable complex interaction and (4-BP)-hERα undergoes less conformational fluctuations compared to the (4-OHT)-hERα. This work reports new synthesis method for 4-BP amino acid with improved anti-estrogenic properties and shed light on its interaction mechanism with hERα.